Orexo AB Capital Markets Day Transcript
¸ - ()-&
Welcome to Orexo's Capital Markets Day. And to say the least, this has not really developed as we had planned. The positive part is that we have more participants than we've had at any other Capital Markets Day, but they're not here in the room with me, but I just heard we have more than 100 people who are connecting in through online means. And I'm pretty sure, there are a lot of people who have -- don't have anything better to do today than to listen to one of the most exciting Swedish pharmaceutical companies, at Orexo. It does sounds like an impressive number, but I'll also, actually, have a special welcome to our field force in the U.S. because we have asked the field force to join us for this call, because you see it's a tremendous opportunity to present our digital therapies, and how we're going to work with that. And I will come back to that a little later. But both investors, who are here in the room, I will say we are within the limits of -- in the U.S. with 10 people in the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
